-transparent.png){kind=logo}
The capacity of human, rabbit and rat liver microsomes and purified isozymes of cytochrome P450 to metabolize theophylline has been assessed. In all three species the 8-hydroxylation of theophylline to 1,3-dimethyluric acid (1,3-DMU) was the major pathway. In human, control rabbit and rat liver microsomes this metabolite accounted for 59, 77 and 94%, respectively, of the total metabolites formed. In both human and control rabbit liver microsomes the N-demethylation of theophylline to 1-methylxanthine (1-MX) accounted for 20% of the total metabolites formed. N-demethylation of theophylline to 3-methylxanthine (3-MX) accounted for 21% of theophylline metabolism in human microsomes but was a minor pathway in control rabbit and rat microsomes. Acetone and phenobarbitone pretreatment markedly increased the formation of 1,3-DMU by rabbit liver microsomes. Rifampicin and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) administration caused a slight but significant increase in this pathway. In general the N-demethylation pathways in rabbit liver microsomes were refractory to induction. In the rat, the metabolism of theophylline to 1-MX, 3-MX and 1,3-DMU were all significantly increased in Aroclor 1254, dexamethasone, phenobarbitone and 3-methylcholanthrene-treated microsomes. In reconstitution experiments the polycyclic hydrocarbon inducible rabbit cytochrome P450 Forms 4 and 6 and the constitutive Form 3b all metabolized theophylline to its three metabolites. In human liver microsomes from four subjects anti-rabbit cytochrome P450 Form 4 IgG inhibited the metabolism of theophylline to 1-MX, 3-MX and 1,3-DMU by approximately 30%. These data indicate that theophylline is metabolized by multiple forms of cytochrome P450 in human, rabbit and rat liver microsomes.
M E McManus, and
J O Miners, and
D Gregor, and
I Stupans, and
D J Birkett
September 2001,
Drug metabolism and disposition: the biological fate of chemicals,
M E McManus, and
J O Miners, and
D Gregor, and
I Stupans, and
D J Birkett
December 2010,
Drug metabolism and disposition: the biological fate of chemicals,
M E McManus, and
J O Miners, and
D Gregor, and
I Stupans, and
D J Birkett
August 1998,
Chemical research in toxicology,
M E McManus, and
J O Miners, and
D Gregor, and
I Stupans, and
D J Birkett
September 2006,
Xenobiotica; the fate of foreign compounds in biological systems,
M E McManus, and
J O Miners, and
D Gregor, and
I Stupans, and
D J Birkett
June 1995,
Carcinogenesis,
M E McManus, and
J O Miners, and
D Gregor, and
I Stupans, and
D J Birkett
July 2006,
Drug metabolism and disposition: the biological fate of chemicals,
M E McManus, and
J O Miners, and
D Gregor, and
I Stupans, and
D J Birkett
November 1994,
Biochemical pharmacology,
M E McManus, and
J O Miners, and
D Gregor, and
I Stupans, and
D J Birkett
May 2002,
Chemico-biological interactions,
M E McManus, and
J O Miners, and
D Gregor, and
I Stupans, and
D J Birkett
August 1999,
Chemico-biological interactions,
M E McManus, and
J O Miners, and
D Gregor, and
I Stupans, and
D J Birkett
October 2001,
Chemical research in toxicology,
